Cite
APA Citation
George, S., Motzer, R., Hammers, H., Redman, B., Kuzel, T., Tykodi, S., Plimack, E., Jiang, J., Waxman, I., & Rini, B. (n.d.). 501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial. European journal of cancer, 51, S102–S103. http://access.bl.uk/ark:/81055/vdc_100030628020.0x000017